Inositol: History of an effective therapy for Polycystic Ovary Syndrome

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 13, 2014, Pages 1896-1903

  Bizzarri, M ^a   Carlomagno, Gianfranco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LoLiPharma srl Medical Department ^*  (Italy)

Author keywords

Inositol; PCOS; Polycistic ovary syndrome

Indexed keywords

FOLLITROPIN; INOSITOL; INSULIN; THYROTROPIN; VITAMIN B COMPLEX;

ARTICLE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INFERTILITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; OOCYTE; OVARY POLYCYSTIC DISEASE; SECOND MESSENGER; ANIMAL; FEMALE; HISTORY; POLYCYSTIC OVARY SYNDROME;

ANIMALS; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INOSITOL; POLYCYSTIC OVARY SYNDROME; VITAMIN B COMPLEX;

EID: 84926075376     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Kompanje Ej, Jansen Tc, Van Der Hoven B, Bakker J. The First Demonstration Of Lactic Acid In Human Blood In Shock By Johann Joseph Scherer (1814-1869) In January 1843. Intensive Care Med 2007; 33: 1967-1971
2. Buttner J. [Johann Joseph Von Scherer (1814-69). The Early History Of Clinical Chemistry]. J Clin Chem Clin Biochem 1978; 16: 478-483
3. The Cell Biology Of Inositol Lipids And Phosphates. Proceedings Of The 2006 Biochemical Society Annual Symposium. Birmingham, United Kingdom. March 29-30, 2006. Biochemical Society Symposium. 2007(74): Pp. 1-271
4. Agranoff Bw. Turtles All The Way: Reflections On Myo-Inositol. J Biol Chem 2009; 284: 21121-21126
5. Hartig T. Ueber Das Klebermehl. Botanische Zeitung 1855; 13: 881
6. Anderson Rj. A Contribution To The Chemistry Of Phytin: I. Composition Of Barium Phytate And Phytic Acid. Ii. A Study Of The Properties Of Phytic Acid And Its Decomposition Products. Eighth Paper On Phytin. J Biol Chem 1914; 17: 171-190
7. Johnson Lf, Tate Me. The Structure Of Myo-Inositol Pentaphosphates. Ann N Y Acad Sci 1969; 165: 526-532
8. Raboy V. Myo-Inositol-1,2,3,4,5,6-Hexakisphosphate. Phytochemistry 2003; 64: 1033-1043
9. Clements Rs, Jr., Darnell B. Myo-Inositol Content Of Common Foods: Development Of A High-Myoinositol Diet. Am J Clin Nutr 1980; 33: 1954-1967
10. Majumder Al, Biswas Bb. Biology Of Inositols And Phoshoinositides. Subcellular Biochemistry. Springer, 2006; P. 39
11. Eisenberg F, Bolden Ah, Loewus Fa. Inositol Formation By Cyclization Of Glucose Chain In Rat Testis. Biochem Biophys Res Commun 1964; 14: 419-424
12. Eisenberg F, Jr., Bolden Ah. Reproductive Tract As Site Of Synthesis And Secretion Of Inositol In The Male Rat. Nature 1964; 202: 599-600
13. Voglmayr Jk, Amann Rp. The Distribution Of Free Myo-Inositol In Fluids, Spermatozoa, And Tissues Of The Bull Genital Tract And Observations On Its Uptake By The Rabbit Epididymis. Biol Reprod 1973; 8: 504-513
14. Lewin Lm, Beer R. Prostatic Secretion As The Source Of Myo-Inositol In Human Seminal Fluid. Fertil Steril 1973; 24: 666-670
15. Ghafoorunissa. Effect Of Dietary Protein & Inositol On Sperm Metabolism & Fructose Content Of Male Accessory Sex Organs Of Rat. Indian J Exp Biol 1976; 14: 564-566
16. Spector R, Lorenzo Av. The Origin Of Myo-Inositol In Brain, Cerebrospinal Fluid And Choroid Plexus. J Neurochem 1975; 25: 353-354
17. Spector R, Lorenzo Av. Myo-Inositol Transport In The Central Nervous System. Am J Physiol 1975; 228: 1510-1518
18. Bromberg Wj, Edlich Rf. Joseph Larner's Personal Odyssey: Search For The Cause And Cure Of Non-Insulin-Dependent Diabetes Mellitus. J Emerg Med 1994; 12: 681-684
19. Larner J, Huang Lc, Tang G, Suzuki S, Schwartz Cf, Romero G, Roulidis Z, Zeller K, Shen Ty, Oswald As, Et Al. Insulin Mediators: Structure And Formation. Cold Spring Harb Symp Quant Biol 1988; 53 Pt 2: 965-971
20. Kennington As, Hill Cr, Craig J, Bogardus C, Raz I, Ortmeyer Hk, Hansen Bc, Romero G, Larner J. Low Urinary Chiro-Inositol Excretion In Non-Insulindependent Diabetes Mellitus. N Engl J Med 1990; 323: 373-378
21. Loewus Mw, Wright Rw, Jr., Bondioli Kr, Bedgar Dl, Karl A. Activity Of Myo-Inositol-1-Phosphate Synthase In The Epididymal Spermatozoa Of Rams. J Reprod Fertil 1983; 69: 215-220
22. O Ortmeyer Hk, Bodkin Nl, Lilley K, Larner J, Hansen Bc. Chiroinositol Deficiency And Insulin Resistance. I. Urinary Excretion Rate Of Chiroinositol Is Directly Associated With Insulin Resistance In Spontaneously Diabetic Rhesus Monkeys. Endocrinology 1993; 132: 640-645
23. Suzuki S, Kawasaki H, Satoh Y, Ohtomo M, Hirai M, Hirai A, Hirai S, Onoda M, Matsumoto M, Hinokio Y, Et Al. Urinary Chiro-Inositol Excretion Is An Index Marker Of Insulin Sensitivity In Japanese Type Ii Diabetes. Diabetes Care 1994; 17: 1465-1468
24. Pak Y, Huang Lc, Lilley Kj, Larner J. In Vivo Conversion Of [3H]Myoinositol To [3H]Chiroinositol In Rat Tissues. J Biol Chem 1992; 267: 16904-16910
25. Pak Y, Paule Cr, Bao Yd, Huang Lc, Larner J. Insulin Stimulates The Biosynthesis Of Chiro-Inositolcontaining Phospholipids In A Rat Fibroblast Line Expressing The Human Insulin Receptor. Proc Natl Acad Sci U S A 1993; 90: 7759-7763
26. Pak Y, Hong Y, Kim S, Piccariello T, Farese Rv, Larner J. In Vivo Chiro-Inositol Metabolism In The Rat: A Defect In Chiro-Inositol Synthesis From Myo-Inositol And An Increased Incorporation Of Chiro-[3H]Inositol Into Phospholipid In The Goto-Kakizaki (G.K) Rat. Mol Cells 1998; 8: 301-309
27. Sun Th, Heimark Db, Nguygen T, Nadler Jl, Larner J. Both Myo-Inositol To Chiro-Inositol Epimerase Activities And Chiro-Inositol To Myo-Inositol Ratios Are Decreased In Tissues Of Gk Type 2 Diabetic Rats Compared To Wistar Controls. Biochem Biophys Res Commun 2002; 293: 1092-1098
28. Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H. The Prevalence Of Polycystic Ovaries In Healthy Women. Acta Obstet Gynecol Scand 1999; 78: 137-141
29. Nestler Je. Role Of Hyperinsulinemia In The Pathogenesis Of The Polycystic Ovary Syndrome, And Its Clinical Implications. Semin Reprod Endocrinol 1997; 15: 111-122
30. Baillargeon Jp, Iuorno Mj, Nestler Je. Insulin Sensitizers For Polycystic Ovary Syndrome. Clin Obstet Gynecol 2003; 46: 325-340
31. Genazzani Ad, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O. Metformin Administration Modulates And Restores Luteinizing Hormone Spontaneous Episodic Secretion And Ovarian Function In Nonobese Patients With Polycystic Ovary Syndrome. Fertil Steril 2004; 81: 114-119
32. Ciampelli M, Fulghesu Am, Cucinelli F, Pavone V, Ronsisvalle E, Guido M, Caruso A, Lanzone A. Impact Of Insulin And Body Mass Index On Metabolic And Endocrine Variables In Polycystic Ovary Syndrome. Metabolism 1999; 48: 167-172
33. Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects Of Myo-Inositol In Women With Pcos: A Systematic Review Of Randomized Controlled Trials. Gynecol Endocrinol 2012; 28: 509-515
34. Dunaif A. Insulin Resistance In Women With Polycystic Ovary Syndrome. Fertil Steril 2006; 86(Suppl 1): S13-14
35. Pasquali R, Pelusi C, Ragazzini C, Hasanaj R, Gambineri A. Glucose Tolerance, Insulin Secretion And Insulin Sensitivity In Polycystic Ovary Syndrome. Jop J Pancreas (Online) 2002; 3: 1-7
36. Genazzani Ad, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni Vm. Metformin Administration Is More Effective When Non-Obese Patients With Polycystic Ovary Syndrome Show Both Hyperandrogenism And Hyperinsulinemia. Gynecol Endocrinol 2007; 23: 146-152
37. Pasquali R, Gambineri A. Insulin-Sensitizing Agents In Polycystic Ovary Syndrome. Eur J Endocrinol 2006; 154: 763-775
38. Nestler Je, Jakubowicz Dj. Lean Women With Polycystic Ovary Syndrome Respond To Insulin Reduction With Decreases In Ovarian P450C17 Alpha Activity And Serum Androgens. J Clin Endocrinol Metab 1997; 82: 4075-4079
39. Nestler Je. Metformin For The Treatment Of The Polycystic Ovary Syndrome. N Engl J Med 2008; 358: 47-54
40. Lord Jm, Flight Ih, Norman Rj. Metformin In Polycystic Ovary Syndrome: Systematic Review And Meta-Analysis. Br Med J 2003; 327: 951-953
41. Asplin I, Galasko G, Larner J. Chiro-Inositol Deficiency And Insulin Resistance: A Comparison Of The Chiro-Inositol-And The Myo-Inositol-Containing Insulin Mediators Isolated From Urine, Hemodialysate, And Muscle Of Control And Type Ii Diabetic Subjects. Proc Natl Acad Sci U S A 1993; 90: 5924-5928
42. Cohen P. The Twentieth Century Struggle To Decipher Insulin Signalling. Nat Rev Mol Cell Biol 2006; 7: 867-873
43. Baillargeon Jp, Nestler Je, Ostlund Re, Apridonidze T, Diamanti-Kandarakis E. Greek Hyperinsulinemic Women, With Or Without Polycystic Ovary Syndrome, Display Altered Inositols Metabolism. Hum Reprod 2008; 23: 1439-1446
44. Baillargeon Jp, Diamanti-Kandarakis E, Ostlund Re, Jr., Apridonidze T, Iuorno Mj, Nestler Je. Altered D-Chiro-Inositol Urinary Clearance In Women With Polycystic Ovary Syndrome. Diabetes Care 2006; 29: 300-305
45. Nestler Je, Jakubowicz Dj, Reamer P, Gunn Rd, Allan G. Ovulatory And Metabolic Effects Of D-Chiroinositol In The Polycystic Ovary Syndrome. N Engl J Med 1999; 340: 1314-1320
46. Iuorno Mj, Jakubowicz Dj, Baillargeon Jp, Dillon P, Gunn Rd, Allan G, Nestler Je. Effects Of D-Chiroinositol In Lean Women With The Polycystic Ovary Syndrome. Endocr Pract 2002; 8: 417-423
47. Cheang Ki, Baillargeon Jp, Essah Pa, Ostlund Re, Jr., Apridonize T, Islam L, Nestler Je. Insulin-Stimulated Release Of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator Correlates With Insulin Sensitivity In Women With Polycystic Ovary Syndrome. Metabolism 2008; 57: 1390-1397
48. Chiu Tt, Tam Pp. A Correlation Of The Outcome Of Clinical In Vitro Fertilization With The Inositol Content And Embryotrophic Properties Of Human Serum. J Assist Reprod Genet 1992; 9: 524-530
49. Sussman I, Matschinsky Fm. Diabetes Affects Sorbitol And Myo-Inositol Levels Of Neuroectodermal Tissue During Embryogenesis In Rat. Diabetes 1988; 37: 974-981
50. Weigensberg Mj, Garcia-Palmer Fj, Freinkel N. Uptake Of Myo-Inositol By Early-Somite Rat Conceptus. Transpor T Kinetics And Effects Of Hyperglycemia. Diabetes 1990; 39: 575-582
51. Chiu Tt, Rogers Ms, Law El, Briton-Jones Cm, Cheung Lp, Haines Cj. Follicular Fluid And Serum Concentrations Of Myo-Inositol In Patients Undergoing Ivf: Relationship With Oocyte Quality. Hum Reprod 2002; 17: 1591-1596
52. Papaleo E, Unfer V, Baillargeon Jp, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A. Myo-Inositol In Patients With Polycystic Ovary Syndrome: A Novel Method For Ovulation Induction. Gynecol Endocrinol 2007; 23: 700-703
53. Gerli S, Papaleo E, Ferrari A, Di Renzo Gc. Randomized, Double Blind Placebo-Controlled Trial: Effects Of Myo-Inositol On Ovarian Function And Metabolic Factors In Women With Pcos. Eur Rev Med Pharmacol Sci 2007; 11: 347-354
54. Genazzani Ad, Lanzoni C, Ricchieri F, Jasonni Vm. Myo-Inositol Administration Positively Affects Hyperinsulinemia And Hormonal Parameters In Overweight Patients With Polycystic Ovary Syndrome. Gynecol Endocrinol 2008; 24: 139-144
55. Zacche Mm, Caputo L, Filippis S, Zacche G, Dindelli M, Ferrari A. Efficacy Of Myo-Inositol In The Treatment Of Cutaneous Disorders In Young Women With Polycystic Ovary Syndrome. Gynecol Endocrinol 2009; 25: 508-513
56. Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic And Hormonal Effects Of Myo-Inositol In Women With Polycystic Ovary Syndrome: A Doubleblind Trial. Eur Rev Med Pharmacol Sci 2009; 13: 105-110
57. Papaleo E, Unfer V, Baillargeon Jp, Fusi F, Occhi F, De Santis L. Myo-Inositol May Improve Oocyte Quality In Intracytoplasmic Sperm Injection Cycles. A Prospective, Controlled, Randomized Trial. Fertil Steril 2009; 91: 1750-1754
58. Rizzo P, Raffone E, Benedetto V. Effect Of The Treatment With Myo-Inositol Plus Folic Acid Plus Melatonin In Comparison With A Treatment With Myo-Inositol Plus Folic Acid On Oocyte Quality And Pregnancy Outcome In Ivf Cycles. A Prospective, Clinical Trial. Eur Rev Med Pharmacol Sci 2010; 14: 555-561
59. Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-Inositol Rather Than D-Chiro-Inositol Is Able To Improve Oocyte Quality In Intracytoplasmic Sperm Injection Cycles. A Prospective, Controlled, Randomized Trial. Eur Rev Med Pharmacol Sci 2011; 15: 452-457
60. Harwood K, Vuguin P, Dimartino-Nardi J. Current Approaches To The Diagnosis And Treatment Of Polycystic Ovarian Syndrome In Youth. Horm Res 2007; 68: 209-217
61. Matalliotakis I, Kourtis A, Koukoura O, Panidis D. Polycystic Ovary Syndrome: Etiology And Pathogenesis. Arch Gynecol Obstet 2006; 274: 187-197
62. Rice S, Christoforidis N, Gadd C, Nikolaou D, Seyani L, Donaldson A, Margara R, Hardy K, Franks S. Impaired Insulin-Dependent Glucose Metabolism In Granulosa-Lutein Cells From Anovulatory Women With Polycystic Ovaries. Hum Reprod 2005; 20: 373-381
63. Carlomagno G, Unfer V, Roseff S. The D-Chiroinositol Paradox In The Ovary. Fertil Steril 2011; 95: 2515-2516
64. Chattopadhayay R, Ganesh A, Samanta J, Jana Sk, Chakravarty Bn, Chaudhury K. Effect Of Follicular Fluid Oxidative Stress On Meiotic Spindle Formation In Infertile Women With Polycystic Ovarian Syndrome. Gynecol Obstet Invest 2010; 69: 197-202
65. Homburg R, Orvieto R, Bar-Hava I, Ben-Rafael Z. Serum Levels Of Insulin-Like Growth Factor-1, Igf Binding Protein-1 And Insulin And The Response To Human Menopausal Gonadotrophins In Women With Polycystic Ovary Syndrome. Hum Reprod 1996; 11: 716-719
66. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects Of Myo-Inositol Supplementation On Oocyte's Quality In Pcos Patients: A Double Blind Trial. Eur Rev Med Pharmacol Sci 2011; 15: 509-514
67. Pal L, Jindal S, Witt Br, Santoro N. Less Is More: Increased Gonadotropin Use For Ovarian Stimulation Adversely Influences Clinical Pregnancy And Live Birth After In Vitro Fertilization. Fertil Steril 2008; 89: 1694-1701
68. Isabella R, Raffone E. Does Ovary Need D-Chiroinositol? J Ovarian Res 2012; 5: 14
69. Galletta M, Grasso S, Vaiarelli A, Roseff Sj. Byebye Chiro-Inositol-Myo- Inositol: True Progress In The Treatment Of Polycystic Ovary Syndrome And Ovulation Induction. Eur Rev Med Pharmacol Sci 2011; 15: 1212-1214
70. Carlomagno G, De Grazia S, Unfer V, Manna F. Myo-Inositol In A New Pharmaceutical Form: A Step Forward To A Broader Clinical Use. Expert Opin Drug Deliv 2012; 9: 267-271
71. Nordio M, Proietti E. The Combined Therapy With Myo-Inositol And D-Chiro-Inositol Reduces The Risk Of Metabolic Disease In Pcos Overweight Patients Compared To Myo-Inositol Supplementation Alone. Eur Rev Med Pharmacol Sci 2012; 16: 575-581.